GHO Capital Partners related stories
All articles and analysis
GHO Capital Partners raises €975mThe London-based investment firm closed its second growth healthcare fund above its target.
GHO Capital Fund II raises 975 mln eurosGHO Capital Fund II LP exceeded its target of 800 million euros
Arsenal buys GHO's Caprion Biosciences, will merge with HistoGeneXU.K. healthcare private equity firm GHO Capital Partners has sold Caprion Biosciences, a Montréal-based provider of immunology and proteomics services to the biopharmaceutical industry. No financial terms were disclosed. The buyer was Arsenal Capital Partners, a U.S. healthcare and specialty industrials private equity firm. In a separate release https://www.arsenalcapital.com/news/caprion-biosciences-and-histogenex-unite-businesses-create-global-leader-immune-monitoring-and Arsenal said it will invest in Caprion's merger with Antwerp, Belgium-based HistoGeneX, creating a single provider of research services for the development of immunology- and oncology-focused drugs. HistoGeneX was formerly backed by Waterland Private Equity Investments. Founded in 2000, Caprion was acquired and recapitalized in 2016 by GHO.
Sector specialisation: Long delayed in Europe, now gaining tractionAs the evolving PE landscape poses challenges for generalists, will sector specialists finally come to the fore in Europe, asks Monument Group's Janet Brooks.
GHO-backed Caprion acquires Belgian immune monitoring labCaprion Biosciences Inc has bought the assets of ImmuneHealth ASBL's immune monitoring laboratory in Gosselies, Belgium. No financial terms were disclosed. Montréal-based Caprion said the acquisition will help expand its immune monitoring offering and strengthen its business partnerships and research collaborations in Europe. It will also diversify the company's services offering in the areas of infectious diseases and vaccine development. The add-on deal is Caprion's first since its acquisition in July /canada/2016/7/gho-capital-buys/ by GHO Capital Partners. The seller was Chicago Growth Partners.
GHO Capital buys Caprion from Chicago Growth PartnersCaprion Biosciences Inc has been recapitalized and acquired by GHO Capital Partners, a European healthcare investment firm. No financial terms were released. The seller in the deal is Chicago Growth Partners, a U.S. private equity firm that led the buyout of Caprion in mid-2012. Montréal-based Caprion is a provider of immunology and proteomics analytical laboratory services to pharmaceutical and biotechnology companies. It said the new partnership with GHO will support further broadening of the company's customer base and expansion in Europe and elsewhere around the globe.
- The rise of European sector specialists?
As firms compete for capital and returns, sector specialisation may be gaining ground.
- GHO debuts with DNA Diagnostics
The Europe-focused healthcare firm’s acquisition of DNA Diagnostics is its first from its debut fund.